Ajanta Pharma Ltd

NSE: AJANTPHARM · BSE: 532331 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹3,573.90
Market cap: ₹44,659 Cr
Revenue (annual): ₹5,453 Cr
Net profit (annual): ₹1,056 Cr
P/E (TTM): 39.4×Sector 47.4×
Promoter holding: 63.48%-2.77% QoQ
FII holding: 7.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Share Pledge 12 Financial Results 4 Earnings Call 3 Board Meeting Outcome 3 Other Announcement 2 Employee Stock Options 2 Annual General Meeting 2 Promoter Selling 1 Legal & Regulatory 1 Dividend 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Apr 2026 08:34 IST BSE

Legal & Regulatory

Ajanta Pharma Legal & Regulatory

Ajanta Pharma announced the conclusion of a US FDA inspection at its Paithan facility. The audit, conducted from April 13 to April 21, 2026, ended with five Form-483 observations. The company stated it will respond to the regulator within the stipulated timeline.

Read the filing ↗